THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment
5:30 PM – 6:00 PM Registration/Dinner
6:00 PM – 8:00 PM Meeting
Miami Marriott Biscayne Bay
1633 N Bayshore Drive
Miami, FL, 33132-1215
Meeting Room: Salon F
- Create your own Personalized Poster
- Interactive, case-based learning environment
- iPads provided to enhance learning experience
- 3D videos and glasses provided for all attendees
Jack D. Schim, MD, FAHS
The Neurology Center of Southern California
Co-director, The Headache Center, Carlsbad
Scripps Memorial Hospital-Encinitas
Assistant Clinical Professor of Neurology UCSD
San Diego, CA
Anne H. Calhoun, MD, FAHS
Partner/Co-Founder, Carolina Headache Institute
Professor, Department of Anesthesiology
Professor, Department of Psychiatry
University of North Carolina
Chapel Hill, NC
This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.
After completing the CME activity, learners should be better able to:
- Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
- Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including diﬀerential diagnosis from other conditions causing headache.
- Discuss the established acute and preventive therapeutic options for patients with migraine.
- Describe publicly available safety and eﬃcacy ﬁndings from recent clinical trials investigating novel therapies for the management of migraine.
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)TM.
Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSING CREDIT INFORMATION
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN
Purpose: This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.
Credits: 2.00 ANCC Contact Hour(s)
Amedco is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of this program qualiﬁes for up to 2 contact hours. Full attendance is required. No partial contact hours will be awarded for partial attendance. UAN: 0453-9999-17-347-L04(K)
ABIM MAINTENANCE OF CERTIFICATION
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Information of physician learners in this activity will be shared with ABIM through PARS.
This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.
This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017,has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at email@example.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at firstname.lastname@example.org